AlphaTON Capital (ATON)
NASDAQ:ATON
Want to see ATON full AI Analyst Report?
ATON Stock Chart & Stats
$0.61
--
Market closed
$0.61
--
Day’s Range― - ―
52-Week Range$0.28 - $15.82
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.13M
Market Cap
$7.94M
Enterprise Value$548.57K
Total Cash (Recent Filing)$183.00K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.04
Next Earnings
Jul 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding23,434,587
10 Day Avg. Volume2,947,603
30 Day Avg. Volume1,125,115
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)-88.97
Price to Sales (P/S)0.00
P/FCF Ratio-2.00
Enterprise Value/Market Cap0.07
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.03
Forecast
1Y Price Target
$2.00Price Target Upside227.87% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-29.6
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring AI Infrastructure RevenueGenerating recurring inference revenue for Telegram’s Cocoon AI signals a move toward predictable, utility-style income. Over 2–6 months, continued uptake of confidential AI rentals can stabilize top-line growth and support operating leverage as fixed server costs scale across customers.
Access To High-end GPU Supply Via Capital-efficient LeasesSecuring scarce NVIDIA B200/B300 capacity through leasing demonstrates operational strength and differentiated sourcing. Capital-efficient acquisitions reduce upfront capex, speed go-to-market for compute services, and improve return on invested capital if utilization and hourly rentals remain steady.
Monetization Of Non-core Biotech To Cut Burn And Preserve UpsideOptioning iOx to Immunova transfers near-term development cost and execution risk while retaining milestone and royalty upside. This structural move reduces ongoing R&D cash needs, sharpens strategic focus on AI infrastructure, and preserves potential long-term value without incremental burn.
Bears Say
No Reported Revenue And Persistent LossesA zero historical revenue base with multi-year net losses indicates the company lacks a proven, diversified revenue model. Durable recovery requires consistent revenue generation; until that occurs, cash runway, margin sustainability, and the path to profitability remain uncertain.
Eroded Shareholders' EquityEquity deterioration to slightly negative reduces the capital buffer available to absorb future losses, weakens lender and partner confidence, and constrains strategic flexibility. Over months this elevates funding risk and could force dilutive financing or asset sales to restore solvency.
Reliance On Large Equity Financing ProgramsDependence on sizeable ATM equity capacity signals ongoing funding needs to scale GPU deployments. Repeated equity issuance can dilute shareholders and reflects limited internal cash generation; sustained reliance on external capital heightens liquidity risk if market access tightens.
AlphaTON Capital News
ATON FAQ
What was AlphaTON Capital’s price range in the past 12 months?
AlphaTON Capital lowest stock price was $0.28 and its highest was $15.82 in the past 12 months.
What is AlphaTON Capital’s market cap?
AlphaTON Capital’s market cap is $7.94M.
When is AlphaTON Capital’s upcoming earnings report date?
AlphaTON Capital’s upcoming earnings report date is Jul 23, 2026 which is in 97 days.
How were AlphaTON Capital’s earnings last quarter?
Currently, no data Available
Is AlphaTON Capital overvalued?
According to Wall Street analysts AlphaTON Capital’s price is currently Undervalued.
Does AlphaTON Capital pay dividends?
AlphaTON Capital does not currently pay dividends.
What is AlphaTON Capital’s EPS estimate?
AlphaTON Capital’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AlphaTON Capital have?
AlphaTON Capital has 23,434,587 shares outstanding.
What happened to AlphaTON Capital’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of AlphaTON Capital?
Currently, no hedge funds are holding shares in ATON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AlphaTON Capital
AlphaTON Capital Corp. is the rebranded entity formerly known as Portage Biotech Inc., a clinical-stage immuno-oncology company transitioning into a digital asset treasury model focused on accumulating and staking Toncoin (TON). AlphaTON intends to invest significantly in TON tokens, targeting a Long-Term TON treasury of approximately US $100 million.
ATON Stock 12 Month Forecast
Average Price Target
$2.00
▲(227.87% Upside)
Technical Analysis
Can-Fite BioPharma
―
Phio Pharmaceuticals
―
Cellectar Biosciences
―
MetaVia
―
Bolt Biotherapeutics
―
Ownership Overview
―
Insiders
<0.01% Mutual Funds
0.08% Other Institutional Investors
99.92% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---